165 related articles for article (PubMed ID: 34197606)
1. PARP1 and CHK1 coordinate PLK1 enzymatic activity during the DNA damage response to promote homologous recombination-mediated repair.
Peng B; Shi R; Bian J; Li Y; Wang P; Wang H; Liao J; Zhu WG; Xu X
Nucleic Acids Res; 2021 Jul; 49(13):7554-7570. PubMed ID: 34197606
[TBL] [Abstract][Full Text] [Related]
2. Plk1 and CK2 act in concert to regulate Rad51 during DNA double strand break repair.
Yata K; Lloyd J; Maslen S; Bleuyard JY; Skehel M; Smerdon SJ; Esashi F
Mol Cell; 2012 Feb; 45(3):371-83. PubMed ID: 22325354
[TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase 1 mediates BRCA1 phosphorylation and recruitment at DNA double-strand breaks.
Chabalier-Taste C; Brichese L; Racca C; Canitrot Y; Calsou P; Larminat F
Oncotarget; 2016 Jan; 7(3):2269-83. PubMed ID: 26745677
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
Tsvetkov L; Stern DF
Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
[TBL] [Abstract][Full Text] [Related]
5. A PIM-CHK1 signaling pathway regulates PLK1 phosphorylation and function during mitosis.
Adam K; Cartel M; Lambert M; David L; Yuan L; Besson A; Mayeux P; Manenti S; Didier C
J Cell Sci; 2018 Aug; 131(15):. PubMed ID: 29976560
[TBL] [Abstract][Full Text] [Related]
6. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer.
Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963582
[TBL] [Abstract][Full Text] [Related]
7. TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity.
Moudry P; Watanabe K; Wolanin KM; Bartkova J; Wassing IE; Watanabe S; Strauss R; Troelsgaard Pedersen R; Oestergaard VH; Lisby M; Andújar-Sánchez M; Maya-Mendoza A; Esashi F; Lukas J; Bartek J
J Cell Biol; 2016 Feb; 212(3):281-8. PubMed ID: 26811421
[TBL] [Abstract][Full Text] [Related]
8. PPP4C facilitates homologous recombination DNA repair by dephosphorylating PLK1 during early embryo development.
Dong MZ; Ouyang YC; Gao SC; Ma XS; Hou Y; Schatten H; Wang ZB; Sun QY
Development; 2022 May; 149(10):. PubMed ID: 35546066
[TBL] [Abstract][Full Text] [Related]
9. Fixin' to divide.
Mohammad DH; Yaffe MB
Mol Cell; 2012 Feb; 45(3):273-5. PubMed ID: 22325348
[TBL] [Abstract][Full Text] [Related]
10. Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.
Lin X; Chen D; Zhang C; Zhang X; Li Z; Dong B; Gao J; Shen L
J Exp Clin Cancer Res; 2018 Jun; 37(1):129. PubMed ID: 29954437
[TBL] [Abstract][Full Text] [Related]
11. Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins.
Huang M; Miao ZH; Zhu H; Cai YJ; Lu W; Ding J
Mol Cancer Ther; 2008 Jun; 7(6):1440-9. PubMed ID: 18566216
[TBL] [Abstract][Full Text] [Related]
12. The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.
Bahassi EM; Ovesen JL; Riesenberg AL; Bernstein WZ; Hasty PE; Stambrook PJ
Oncogene; 2008 Jun; 27(28):3977-85. PubMed ID: 18317453
[TBL] [Abstract][Full Text] [Related]
13. Aurora-A expressing tumour cells are deficient for homology-directed DNA double strand-break repair and sensitive to PARP inhibition.
Sourisseau T; Maniotis D; McCarthy A; Tang C; Lord CJ; Ashworth A; Linardopoulos S
EMBO Mol Med; 2010 Apr; 2(4):130-42. PubMed ID: 20373286
[TBL] [Abstract][Full Text] [Related]
14. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
Lee HJ; Hwang HI; Jang YJ
Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
[TBL] [Abstract][Full Text] [Related]
15. Polo-like kinase 1 inhibits DNA damage response during mitosis.
Benada J; Burdová K; Lidak T; von Morgen P; Macurek L
Cell Cycle; 2015; 14(2):219-31. PubMed ID: 25607646
[TBL] [Abstract][Full Text] [Related]
16. The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers.
Marzio A; Puccini J; Kwon Y; Maverakis NK; Arbini A; Sung P; Bar-Sagi D; Pagano M
Mol Cell; 2019 Jan; 73(2):224-237.e6. PubMed ID: 30554948
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting polo-like kinase 1 enhances radiosensitization via modulating DNA repair proteins in non-small-cell lung cancer.
Yao D; Gu P; Wang Y; Luo W; Chi H; Ge J; Qian Y
Biochem Cell Biol; 2018 Jun; 96(3):317-325. PubMed ID: 29040814
[TBL] [Abstract][Full Text] [Related]
18. PLK1 targets CtIP to promote microhomology-mediated end joining.
Wang H; Qiu Z; Liu B; Wu Y; Ren J; Liu Y; Zhao Y; Wang Y; Hao S; Li Z; Peng B; Xu X
Nucleic Acids Res; 2018 Nov; 46(20):10724-10739. PubMed ID: 30202980
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora.
Bruinsma W; Aprelia M; García-Santisteban I; Kool J; Xu YJ; Medema RH
Oncogene; 2017 Mar; 36(13):1840-1848. PubMed ID: 27721411
[TBL] [Abstract][Full Text] [Related]
20. Mitotic entry upon Topo II catalytic inhibition is controlled by Chk1 and Plk1.
Arroyo M; Cañuelo A; Calahorra J; Hastert FD; Sánchez A; Clarke DJ; Marchal JA
FEBS J; 2020 Nov; 287(22):4933-4951. PubMed ID: 32144855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
